1. Messenger AG, McKillop J, Farrant P, McDonagh AJ, Sladden M. British Association of Dermatologists' guidelines for the management of alopecia areata 2012. Br J Dermatol. 2012; 166:916–926.
Article
2. Day H, Jutai J. Measuring the psychosocial impact of assistive devices: the PIADS. Can J Rehabilit. 1996; 9:159–168.
3. Chae SY, Jo SJ, Kwon HC, Kong JY, Chang MY. A study on a Korean translated version of the psychosocial impact of assistive devices scale (PIADS). Korean Soc Occup Ther. 2008; 16:71–86.
4. Han SH, Byun JW, Lee WS, Kang H, Kye YC, Kim KH, et al. Quality of life assessment in male patients with androgenetic alopecia: result of a prospective, multicenter study. Ann Dermatol. 2012; 24:311–318.
Article
5. Otberg N, Shapiro J. Hair growth disorders. In : Goldsmith LA, Katz SI, Gilchrest BA, Paller AS, Leffell DJ, Wolff K, editors. Fitzpatrick's dermatology in general medicine. 8th ed. New York: McGraw-Hill;2012. p. 979–1008.
6. Draelos ZD. Camouflage technique for alopecia areata: What is a patient to do? Dermatol Ther. 2011; 24:305–310.
Article
7. Lee WS, Lee HJ, Choi GS, Cheong WK, Chow SK, Gabriel MT, et al. Guidelines for management of androgenetic alopecia based on BASP classification--the Asian Consensus Committee guideline. J Eur Acad Dermatol Venereol. 2013; 27:1026–1034.
Article
8. Jang MH, Bae SK. Recognition change before and after wearing wigs of the female cancer patients. J Korea Contents Assoc. 2010; 10:198–205.
Article
9. Inui S, Inoue T, Itami S. Psychosocial impact of wigs or hairpieces on perceived quality of life level in female patients with alopecia areata. J Dermatol. 2013; 40:225–226.
Article